Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation

• Published in: Journal of Cancer Vol. 15; no. 5; pp. 1153 - 1168
• Main Authors: Vernaza, Alexandra, Cardus, Daniela F, Smith, Jadyn L, Partridge, Veronica, Baker, Amy L, Lewis, Emma G, Zhang, Angela, Zhao, Zhenze, Du, Liqin
• Format: Journal Article
• Language: English
• Published: Australia Ivyspring International Publisher 2024
• Subjects: Research Paper; neuroblastoma; differentiation; neurite outgrowth; differentiation therapy; cell cycle regulator
• ISSN: 1837-9664; 1837-9664
• DOI: 10.7150/jca.89660

We conducted a high-content screening (HCS) in neuroblastoma BE(2)-C cells to identify cell cycle regulators that control cell differentiation using a library of siRNAs against cell cycle-regulatory genes. We discovered that knocking down expression of cyclin dependent kinase inhibitor 3 (CDKN3) showed the most potent effect in inducing neurite outgrowth, the morphological cell differentiation marker of neuroblastoma cells. We then demonstrated that CDKN3 knockdown increased expression of neuroblastoma molecular differentiation markers, neuron specific enolase (NSE), βIII-tubulin and growth associated protein 43 (GAP43). We further showed that CDKN3 knockdown reduced expression of cell proliferation markers Ki67 and proliferating cell nuclear antigen (PCNA), and reduced colony formation of neuroblastoma cells. More importantly, we observed a correlation of high tumor CDKN3 mRNA levels with poor patient survival in the investigation of public neuroblastoma patient datasets. In exploring the mechanisms that regulate CDKN3 expression, we found that multiple strong differentiation-inducing molecules, including miR-506-3p and retinoic acid, down-regulated CDKN3 expression. In addition, we found that N-Myc promoted CDKN3 expression at the transcriptional level by directly binding to the CDKN3 promoter. Furthermore, we found that CDKN3 and two additional differentiation-regulating cell cycle proteins identified in our HCS, CDC6 and CDK4, form an interactive network to promote expression of each other. In summary, we for the first time discovered the function of CDKN3 in regulating neuroblastoma cell differentiation and characterized the transcriptional regulation of CDKN3 expression by N-Myc in neuroblastoma cells. Our findings support that CDKN3 plays a role in modulating neuroblastoma cell differentiation and that overexpression of CDKN3 may contribute to neuroblastoma progression.